Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times. - Zhao YJ; Wee HL; Au WL; Seah SH; Luo N; Li SC; Tan LC (Parkinsonism & Related Disorders, 2011)